This study aims to explore the effect of an inhibitor of DNA binding-1 (Id-1) on the proliferation and migration of human colon carcinoma cell line SW480 and HT-29.
This study aims to explore the effect of an inhibitor of DNA binding-1 (Id-1) on the proliferation and migration of human colon carcinoma cell line SW480 and HT-29.
SW480 and HT-29 cells transfected with Id-1-interference sequence were assigned to the experimental groups (inhibition groups 1 and 2), and SW480 and HT-29 cells with blank interference sequence (blank groups) and blank load transfection (blank load groups) were assigned as the control groups. The expression of Id-1 in six groups was detected by reverse transcription-polymerase chain reaction (RT-PCR) and Western blot. Cell proliferation in vitro was assessed by MTT assay.
RT-PCR and Western blot results demonstrated that the mRNA and protein
expressions of Id-1 in the inhibition group 1 were lower than those in the blank group 1 and blank load group 1. RT-PCR and Western blot results revealed that the mRNA and protein expressions of Id-1 were lower in the inhibition group 2 than in the blank group 2 and blank load group 2. The results of the growth curve revealed that proliferation ability was significantly weaker from the third day in the inhibition groups 1 and 2 than in the blank group and blank load group. Transwell chamber experiment and Matrigel invasion assay revealed that the number of Transwell cells significantly decreased in the inhibition groups 1 and 2 than in the blank groups and blank load groups (P < 0.01). Id-1 significantly promotes the proliferation and migration of human colon carcinoma cell lines SW480 and HT-29.
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| INTRODUCTION
Inhibitor of DNA binding-1 (Id-1) is a carcinogenic gene that has been increasingly researched in recent years. This gene can promote cell proliferation, induce the generation of blood vessel endothelia with tumors, and promote tumor growth and invasion. [1] [2] [3] Its overexpression is closely correlated to the occurrence, development, and prognoses of many malignant tumors such as lung cancer, gastric cancer, pancreatic cancer, and cervical cancer. 4 A previous study has suggested that the overexpression of Id-1 is closely correlated to occurrence and development of colorectal cancer. 5 However, there are no detailed reports on its corresponding proliferation in vitro and invasion experiments. In the present study, an interference sequence of Id-1 was introduced into SW480 and HT-29 colon cancer cells to determine changes in its proliferation and metastasis abilities in vitro before and after the gene was interfered, in order to explore the effect of inhibitor of DNA binding-1 (Id-1) on the proliferation and migration of human colon carcinoma cell line SW480 and HT-29.
| MATERIALS AND METHODS

| Materials and main reagents
Human SW480 and HT-29 colon cancer cells were stored at the Scien- 
| Methods
| Cell cultivation
SW480 and HT-29 cells were normally cultivated in RPMI-1640 medium (10% fetal calf serum, 100 μg/mL of streptomycin, and 100 U/mL of penicillin), and proliferated by 0.25% trypsin. Cells in the logarithmic phase were selected. In our study, about 2 weeks were needed for Id-1-interference sequence coculture (or transfection) with cancer cell before harvest for mRNA expression, protein expression, and cell proliferation study.
| Inhibition expression vector construction
One day before transfection, 2. The corresponding software (ABI 7500) was used to quantitatively determine the density. Results were obtained in ultraviolet rays, and Id-1/GAPDH was used for quantitative determination.
| Detection of Id-1 protein expression by Western blot
Total protein was extracted from the RIPA lysate to determine the quantity. Then, 50 μg of protein was placed in 5× buffer (4:1), a 100 C water bath was performed three times for 5 minutes each time, SDS-PAGE was conducted, and protein was transferred onto a polyvinylidene fluoride (PVDF) membrane. The PVDF was removed, and 5% skimmed milk powder was added. The confining liquid was discarded, the specific primary antibody was added (Id-1, 1:1500; GAPDH, 1:150), and incubated at −4 C overnight. Then, Tris-Buffered Saline and Tween 20
(TBST) was added three times in 10 minutes, the specific secondary antibody was added (1:1500), incubated at 37 C for 1 hour. Next, TBST was added again three times in 10 minutes. ECL was adopted to detect bands, and Id-1/GAPDH was used for quantitative determination.
| Detection of the proliferation of cells in all groups by MTT assay
Cells in the logarithmic phase were normally digested and inoculated in 96-well plate at 1 × 10 4 cells/well (200 μL/well). Duplicate wells were set. Cells were inoculated in the medium at 37 C with 5% CO 2 .
Cell lines were surveyed in three duplicate wells with three random types of cells daily. Then, 20 μL of MTT (5 g/L) was added into every well. Cells were cultivated for another 4 hours. The supernatant was discarded, and 150 μL of dimethyl sulfoxide was added into each well.
Cells were shaken for 10 minutes for complete crystallization. The optical density of 492 nm (OD value) was surveyed using the enzymelinked immunosorbent assay meter for the successive 7 days. Then, the growth curves for SW480 and HT-29 cells were drawn. 
| Cell migration and invasion ability survey
| Statistic analysis
SPSS 17.0 statistics software was used, and measurement data were presented as mean ± SD. Single-factor analysis of variance was adopted for comparison among many groups. Dunnett's t-test was adopted for comparisons between two groups. P < 0.05 was considered statistically significant.
| 2. RESULTS
| Id-1 expression results by Western blot and RT-PCR
In the inhibition group 1, the mRNA expression level of Id-1 (0.14 ± 0.02) was significantly lower than that in the blank group 1 (1.27 ± 0.03) and blank load group 1 (1.25 ± 0.06) (P < 0.01), the protein expression level of Id-1 (0.25 ± 0.02) was significantly lower than in the blank group 1 (1.18 ± 0.03) and blank load group 1 (1.16 ± 0.04) (P < 0.01). In the inhibition group 2, the mRNA expression level of Id-1 (0.18 ± 0.01) was significantly lower than that in the blank group 2 (1.29 ± 0.02) and blank load group 2 (1.28 ± 0.02) (P < 0.01) (Figure 1) , the protein expression level of Id-1 (0.21 ± 0.03) was significantly lower than that in the blank group 2 (0.99 ± 0.04) and blank load group 2 (1.11 ± 0.02) (P < 0.01) ( Figure 2 )."
| Cells proliferation ability detection results by MTT assay
The OD values of the SW480 and HT-29 cell lines did not significantly differ, and the growth curves basically overlapped after cultivation for the successive 1 or 2 days. From the third day, proliferation began to decrease in the inhibition groups. From the fourth day, inhibition of growth in the inhibition groups was obvious, and the OD value significantly decreased, compared to the blank groups and blank load groups.
The growth curves of cells in corresponding blank groups and blank load groups were basically close to each other, and there was not much difference in proliferation ability, as shown in Table 1 , Figures 3 and 4 .
| Cell migration and invasion ability detection results
The Transwell chamber migration and Matrigel invasion experiments revealed that the number of cells that passed through the membrane/ matrix in the two inhibition groups significantly decreased compared to Compared with blank and blank load group, P < 0.001.
F I G U R E 3
Results of growth curve of three SW480 groups the corresponding blank groups and blank load groups (P < 0.001).
Furthermore, there was no significant difference in the number of cells that passed through the membrane/matrix between the blank groups and blank load groups (P > 0.001), as shown in Figure 5 . In summary, Id-1 promotes the proliferation and metastasis of SW480 and HT-29 human colonic cancer cells, but its concrete mechanism requires further research, which is our main research orientation in the future.
| DISCUSSION
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